Open AccessClinical and Infection Prevention Applications of Severe Acute Respiratory Syndrome Coronavirus 2 Genotyping: an Infectious Diseases Society of America/American Society for Microbiology Consensus Review Document
Author(s) -
Alexander L. Greninger,
Jennifer Dien Bard,
Robert C. Colgrove,
Erin H. Graf,
Kimberly E. Hanson,
Mary K Hayden,
Romney M. Humphries,
Christopher F. Lowe,
Melissa B. Miller,
Dylan R. Pillai,
Daniel D. Rhoads,
Joseph D. Yao,
Francesca M Lee
Publication year - 2022
Publication title -
journal of clinical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.349
H-Index - 255
eISSN - 1070-633X
pISSN - 0095-1137
DOI - 10.1128/jcm.01659-21
Subject(s) - genotyping , covid-19 , coronavirus , virology , medicine , clinical microbiology , biology , immunology , genotype , infectious disease (medical specialty) , disease , genetics , gene , microbiology and biotechnology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged into a world of maturing pathogen genomics, with more than 2 million genomes sequenced at the time of writing. The rise of more transmissible variants of concern that impact vaccine and therapeutic effectiveness has led to widespread interest in SARS-CoV-2 evolution.